Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation Auditor change Appointed director
|
IMMUNOMEDICS INC (IMMU)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/16/2021 |
SC 13G/A
| Point72 Asset Management, L.P. reports a 0% stake in Immunomedics, Inc. |
11/09/2020 |
SC 13G/A
| BlackRock Inc. reports a 0% stake in IMMUNOMEDICS INC |
11/02/2020 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
10/30/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/30/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/30/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/27/2020 |
4
| Fricker William (Principal Accounting Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 65,310 options to buy
@ $0 |
|
10/23/2020 |
4
| Aghazadeh Behzad (10% Owner) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 13,516 shares
@ $0 Disposed/sold 26,250,000 shares
@ $0 Disposed/sold 202,614 options to buy
@ $0 Disposed/sold 103,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| Malik Usama (Chief Fin. & Business Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 18,856 shares
@ $0 Disposed/sold 386,080 options to buy
@ $0 |
|
10/23/2020 |
4
| Canute Scott A (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 13,516 shares
@ $0 Disposed/sold 155,286 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| Azelby Robert (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 29,040 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| HUTT PETER BARTON (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 13,516 shares
@ $0 Disposed/sold 52,614 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| ITRI LORETTTA M (Chief Medical Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 15,000 shares
@ $0 Disposed/sold 200,000 options to buy
@ $0 |
|
10/23/2020 |
4
| Andrews Kurt J. (Chief Human Resources Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 238,072 options to buy
@ $0 |
|
10/23/2020 |
4
| Islam Khalid (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 13,516 shares
@ $0 Disposed/sold 52,614 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| BALL BRYAN (Chief Quality Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 10,000 shares
@ $0 Disposed/sold 261,937 options to buy
@ $0 |
|
10/23/2020 |
4
| Freedberg Jared (Gen. Counsel & Corp. Secretary) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 280,105 options to buy
@ $0 |
|
10/23/2020 |
4
| Delaney Brendan (Chief Commercial Officer) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 390,460 options to buy
@ $0 |
|
10/23/2020 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 9,667 shares
@ $0 Disposed/sold 46,117 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on IMMUNOMEDICS INC
Txns:
| Disposed/sold 49,244 shares
@ $0 Disposed/sold 6,540 options to buy
@ $0 Disposed/sold 3,718 restricted stock units
@ $0 |
|
10/23/2020 |
SC 13D/A
| venBio Select Advisor LLC reports a 0% stake in Immunomedics, Inc. |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/23/2020 |
8-K
| Resignation/termination of a director |
10/23/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
10/23/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/23/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
10/14/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
10/14/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
|
|
|